Cargando…

Antiretroviral Therapy as Prevention of … Pneumococcal Infections?

BACKGROUND. Despite antiretroviral therapy, it is generally believed that the risk for pneumococcal infections (PnIs) is high among patients infected with human immunodeficiency virus (HIV). However, most studies in this field have been conducted before 2010, and the proportion of virologically supp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lesourd, Anaïs, Leporrier, Jérémie, Delbos, Valérie, Unal, Guillemette, Honoré, Patricia, Etienne, Manuel, Bouchaud, Olivier, Caron, François
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2016
Materias:	Major Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5170497/ https://www.ncbi.nlm.nih.gov/pubmed/28018929 http://dx.doi.org/10.1093/ofid/ofw228

Ejemplares similares

Forgiveness of Dolutegravir-Based Triple Therapy Compared With Older Antiretroviral Regimens: A Prospective Multicenter Cohort of Adherence Patterns and HIV-RNA Replication
por: Parienti, Jean-Jacques, et al.
Publicado: (2021)

Factors Associated With Severe Nonmeningitis Invasive Pneumococcal Disease in Adults in France
por: Danis, Kostas, et al.
Publicado: (2019)

Residual Central Nervous System Immune Activation Is Not Prevented by Antiretroviral Therapy Initiated During Early Chronic HIV Infection
por: Edén, Arvid, et al.
Publicado: (2023)

Association of First-Line and Second-Line Antiretroviral Therapy Adherence
por: Ramadhani, Habib O., et al.
Publicado: (2014)

Distribution of Serotypes Causing Invasive Pneumococcal Disease in Children From High-Income Countries and the Impact of Pediatric Pneumococcal Vaccination
por: Grant, Lindsay R, et al.
Publicado: (2022)

Pneumococcal Conjugate Vaccine Safety in Elderly Adults
por: Tseng, Hung Fu, et al.
Publicado: (2018)

Implication of First-Line Antiretroviral Therapy Choice on Second-Line Options
por: Meloni, Seema T, et al.
Publicado: (2017)

Risk of Acute Liver Injury With Antiretroviral Therapy by Viral Hepatitis Status
por: Gowda, Charitha, et al.
Publicado: (2017)

Rates of Pneumococcal Disease in Adults With Chronic Medical Conditions
por: Shea, Kimberly M., et al.
Publicado: (2014)

Homelessness in Adults With Invasive Pneumococcal Disease in Calgary, Canada
por: Lemay, Julie-Anne, et al.
Publicado: (2019)

Transcriptional Changes in CD8(+) T Cells During Antiretroviral Therapy Intensified With Raltegravir
por: Ouyang, Zhengyu, et al.
Publicado: (2015)

Racial Disparities in Virologic Failure and Tolerability During Firstline HIV Antiretroviral Therapy
por: Bhagwat, Priya, et al.
Publicado: (2019)

Early Antiretroviral Therapy at High CD4 Counts Does Not Improve Arterial Elasticity: A Substudy of the Strategic Timing of AntiRetroviral Treatment (START) Trial
por: Baker, Jason V., et al.
Publicado: (2016)

Improving Influenza and Pneumococcal Vaccination Rates in Ambulatory Specialty Practices
por: Pennant, Keyana N., et al.
Publicado: (2015)

White Blood Cell Counts, Alcoholism, and Cirrhosis in Pneumococcal Pneumonia
por: Gardner, Julianna G., et al.
Publicado: (2017)

Risk of Pneumococcal Disease in US Adults by Age and Risk Profile
por: Grant, Lindsay R, et al.
Publicado: (2023)

Pneumococcal Carriage, Serotype Distribution, and Risk Factors in Children With Community-Acquired Pneumonia, 5 Years After Introduction of the 10-Valent Pneumococcal Conjugate Vaccine in Ethiopia
por: Negash, Abel Abera, et al.
Publicado: (2019)

Changes in the Fungal Marker β-D-Glucan After Antiretroviral Therapy and Association With Adiposity
por: Dirajlal-Fargo, Sahera, et al.
Publicado: (2019)

Factors Associated With Liver Steatosis in People With Human Immunodeficiency Virus on Contemporary Antiretroviral Therapy
por: Riebensahm, Carlotta, et al.
Publicado: (2022)

Cannabis Use Is Associated With Decreased Antiretroviral Therapy Adherence Among Older Adults With HIV
por: Manuzak, Jennifer A, et al.
Publicado: (2023)

Association of Incomplete Adherence to Antiretroviral Therapy With Cardiovascular Events and Mortality in Virologically Suppressed Persons With HIV: The Swiss HIV Cohort Study
por: Castillo-Mancilla, Jose R, et al.
Publicado: (2021)

Short-term Mortality Outcomes of HIV-Associated Cryptococcal Meningitis in Antiretroviral Therapy–Naïve and –Experienced Patients in Sub-Saharan Africa
por: Kalata, Newton, et al.
Publicado: (2021)

Host- and Pathogen-Related Factors for Acute Cardiac Events in Pneumococcal Pneumonia
por: Rombauts, Alexander, et al.
Publicado: (2020)

Reemergence of Invasive Pneumococcal Disease in Germany During the Spring and Summer of 2021( )
por: Perniciaro, Stephanie, et al.
Publicado: (2022)

Cryptococcal Antigenemia in Nigerian Patients With Advanced Human Immunodeficiency Virus: Influence of Antiretroviral Therapy Adherence
por: Oladele, Rita O., et al.
Publicado: (2016)

Efficient HIV-1 Trans Infection of CD4(+) T Cells Occurs in the Presence of Antiretroviral Therapy
por: Rappocciolo, Giovanna, et al.
Publicado: (2019)

Cost-Effectiveness of Preemptive Switching to Efavirenz-Based Antiretroviral Therapy for Children With Human Immunodeficiency Virus
por: Desmonde, Sophie, et al.
Publicado: (2019)

Myocardial Fibrosis Among Antiretroviral Therapy-Treated Persons With Human Immunodeficiency Virus in South Africa
por: Shuldiner, Scott R, et al.
Publicado: (2020)

Recurrent Subclinical Tuberculosis Among Antiretroviral Therapy–Accessing Participants: Incidence, Clinical Course, and Outcomes( )
por: Naidoo, Kogieleum, et al.
Publicado: (2022)

Decline in Pneumococcal Disease in Young Children during the COVID-19 Pandemic in Israel Associated with Suppression of seasonal Respiratory Viruses, despite Persistent Pneumococcal Carriage: A Prospective Cohort Study
por: Danino, Dana, et al.
Publicado: (2021)

Ability to Work and Employment Rates in Human Immunodeficiency Virus (HIV)-1-Infected Individuals Receiving Combination Antiretroviral Therapy: The Swiss HIV Cohort Study
por: Elzi, Luigia, et al.
Publicado: (2016)

Optimal Timing of Antiretroviral Therapy Initiation in Children and Adolescents With Human Immunodeficiency Virus-Associated Pulmonary Tuberculosis
por: Kay, Alexander, et al.
Publicado: (2022)

Impact of Integrase Inhibitors on Cardiovascular Disease Events in People With Human Immunodeficiency Virus Starting Antiretroviral Therapy
por: Surial, Bernard, et al.
Publicado: (2023)

Insight Into Resistance Phenotypes of Emergent Non 13-valent Pneumococcal Conjugate Vaccine Type Pneumococci Isolated From Invasive Disease After 13-valent Pneumococcal Conjugate Vaccine Implementation in France
por: Janoir, Claire, et al.
Publicado: (2016)

Differences in Homing Potentials of Streptococcus pneumoniae–Specific Plasmablasts in Pneumococcal Pneumonia and After Pneumococcal Polysaccharide and Pneumococcal Conjugate Vaccinations
por: Palkola, Nina V., et al.
Publicado: (2015)

Inflammatory Phenotypes Predict Changes in Arterial Stiffness Following Antiretroviral Therapy Initiation
por: Kelly, Christine, et al.
Publicado: (2020)

Impact of Xpert MTB/RIF on Antiretroviral Therapy-Associated Tuberculosis and Mortality: A Pragmatic Randomized Controlled Trial
por: Mupfumi, L., et al.
Publicado: (2014)

High Rates of Occult Hepatitis B Virus Infection in HIV-Positive Individuals Initiating Antiretroviral Therapy in Botswana
por: Ryan, Kathleen, et al.
Publicado: (2017)

Clinical Outcomes Following the Use of Archived Proviral HIV-1 DNA Genotype to Guide Antiretroviral Therapy Adjustment
por: Ellis, Kristen E, et al.
Publicado: (2019)

A Randomized, Placebo-Controlled Trial Assessing the Effect of VISBIOME ES Probiotic in People With HIV on Antiretroviral Therapy
por: Presti, Rachel M, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_880dqh7ahi9n6f22561bf9vjvh